Scalable Life Sciences supported the Top Institute Pharma (TI Pharma) in the area of public affairs.
Top Institute Pharma (TI Pharma) is a public-private partnership
in which scientific and business
worlds work together on groundbreaking, multidisciplinary research aimed at improving the development
of socially valuable medicines. The research portfolio is based on the disease areas as specified in
Priority Medicines, a report by the World Health Organization (WHO). The knowledge gained in these
projects provides an important contribution to better, faster and less-expensive development of valuable